{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:08:13Z","timestamp":1790816893831,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004043","name":"Kanazawa Medical University","doi-asserted-by":"publisher","award":["SR 2012-04"],"award-info":[{"award-number":["SR 2012-04"]}],"id":[{"id":"10.13039\/501100004043","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mesenchymal stem cells (MSCs) are multipotent stromal cells and could exert hepatoprotective effects against acute liver injury, steatohepatitis, and fibrogenesis. Here, we evaluated the effects of human adipose derived stem cells (hADSCs) to attenuate experimentally induced hepatic fibrosis and early cirrhosis in rats.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Hepatic fibrosis was induced by intraperitoneal injections of CCl<jats:sub>4<\/jats:sub> (0.1\u00a0ml\/100\u00a0g body weight) twice a week for 8\u00a0weeks. hADSCs were isolated and cultured on polyethylene discs coated with hydroxyapatite and 2\u00a0cm diameter disc was surgically implanted on the right lateral lobe of the liver. Discs implanted without hADSCs served as control. The animals were injected again with CCl<jats:sub>4<\/jats:sub> once a week for another 8\u00a0weeks. All the animals were sacrificed at the end of 16th week.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Serial administrations of CCl<jats:sub>4<\/jats:sub> resulted in well developed fibrosis and early cirrhosis at 8th week which maintained until the 16th week. Animals treated with hADSC discs depicted over 50% decrease of collagen with significant increase in serum albumin and total protein levels. Immunohistochemical staining for TGF-\u03b21, \u03b1-smooth muscle actin, and collagen type I and type III demonstrated marked decrease compared to the animals without hADSC treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Treatment with hADSCs improved liver functions, markedly reduced hepatic fibrosis and early cirrhosis. Various pleiotropic and paracrine factors secreted from the hADSCs seem to serve as reparative functions in the attenuation of liver cirrhosis. The data demonstrated that treatment with hADSCs can be successfully used as a potent therapeutic method to prevent progression of hepatic fibrosis and related adverse events.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10020-022-00566-6","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T12:08:20Z","timestamp":1669723700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Surgical implantation of human adipose derived stem cells attenuates experimentally induced hepatic fibrosis in rats"],"prefix":"10.1186","volume":"28","author":[{"given":"Masateru","family":"Nomura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5354-7884","authenticated-orcid":false,"given":"Joseph","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieko","family":"Hashizume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimichi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Ishigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsumi","family":"Tsuchishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0463-074X","authenticated-orcid":false,"given":"Mikihiro","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"key":"566_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.671640","volume":"12","author":"P Acharya","year":"2021","unstructured":"Acharya P, Chouhan K, Weiskirchen S, Weiskirchen R. Cellular mechanisms of liver fibrosis. Front Pharmacol. 2021;12: 671640. https:\/\/doi.org\/10.3389\/fphar.2021.671640.","journal-title":"Front Pharmacol"},{"issue":"9","key":"566_CR2","doi-asserted-by":"publisher","first-page":"15297","DOI":"10.1002\/jcb.28797","volume":"120","author":"M Ajami","year":"2019","unstructured":"Ajami M, Soleimani M, Abroun S, Atashi A. Comparison of cord blood CD34 + stem cell expansion in coculture with mesenchymal stem cells overexpressing SDF-1 and soluble \/membrane isoforms of SCF. J Cell Biochem. 2019;120(9):15297\u2013309. https:\/\/doi.org\/10.1002\/jcb.28797.","journal-title":"J Cell Biochem"},{"issue":"11","key":"566_CR3","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.3727\/096368912X657855","volume":"22","author":"F Bianchi","year":"2013","unstructured":"Bianchi F, Maioli M, Leonardi E, Olivi E, Pasquinelli G, Valente S, Mendez AJ, Ricordi C, Raffaini M, Tremolada C, Ventura C. A new nonenzymatic method and device to obtain a fat tissue derivative highly enriched in pericyte-like elements by mild mechanical forces from human lipoaspirates. Cell Transplant. 2013;22(11):2063\u201377. https:\/\/doi.org\/10.3727\/096368912X657855.","journal-title":"Cell Transplant"},{"issue":"3","key":"566_CR4","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1002\/jcp.29169","volume":"235","author":"Z Chen","year":"2020","unstructured":"Chen Z, Wan L, Jin X, Wang W, Li D. Transforming growth factor-\u03b2 signaling confers hepatic stellate cells progenitor features after partial hepatectomy. J Cell Physiol. 2020;235(3):2655\u201367. https:\/\/doi.org\/10.1002\/jcp.29169.","journal-title":"J Cell Physiol"},{"issue":"11","key":"566_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.molmed.2015.09.004","volume":"21","author":"B Christ","year":"2015","unstructured":"Christ B, Br\u00fcckner S, Winkler S. The therapeutic promise of mesenchymal stem cells for liver restoration. Trends Mol Med. 2015;21(11):673\u201386. https:\/\/doi.org\/10.1016\/j.molmed.2015.09.004.","journal-title":"Trends Mol Med"},{"issue":"1","key":"566_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","volume":"44","author":"G D'Amico","year":"2006","unstructured":"D\u2019Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217\u201331. https:\/\/doi.org\/10.1016\/j.jhep.2005.10.013.","journal-title":"J Hepatol"},{"issue":"4","key":"566_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2131\/jts.41.561","volume":"41","author":"S Dong","year":"2016","unstructured":"Dong S, Chen QL, Song YN, Sun Y, Wei B, Li XY, Hu YY, Liu P, Su SB. Mechanisms of CCl4-induced liver fibrosis with combined transcriptomic and proteomic analysis. J Toxicol Sci. 2016;41(4):561\u201372. https:\/\/doi.org\/10.2131\/jts.41.561.","journal-title":"J Toxicol Sci"},{"issue":"2","key":"566_CR8","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.transproceed.2010.02.013","volume":"42","author":"CO Esquivel","year":"2010","unstructured":"Esquivel CO. Liver transplantation: where we are and where we are heading. Transplant Proc. 2010;42(2):610\u20132. https:\/\/doi.org\/10.1016\/j.transproceed.2010.02.013.","journal-title":"Transplant Proc"},{"issue":"4","key":"566_CR9","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000448180","volume":"43","author":"L Frese","year":"2016","unstructured":"Frese L, Dijkman PE, Hoerstrup SP. Adipose tissue-derived stem cells in regenerative medicine. Transfus Med Hemother. 2016;43(4):268\u201374. https:\/\/doi.org\/10.1159\/000448180.","journal-title":"Transfus Med Hemother"},{"issue":"3","key":"566_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1139\/o08-038","volume":"86","author":"J George","year":"2008","unstructured":"George J. Elevated serum beta-glucuronidase reflects hepatic lysosomal fragility following toxic liver injury in rats. Biochem Cell Biol. 2008;86(3):235\u201343. https:\/\/doi.org\/10.1139\/o08-038.","journal-title":"Biochem Cell Biol"},{"issue":"5","key":"566_CR11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1515\/hsz-2017-0260","volume":"399","author":"J George","year":"2018","unstructured":"George J. Determination of selenium during pathogenesis of hepatic fibrosis employing hydride generation and inductively coupled plasma mass spectrometry. Biol Chem. 2018;399(5):499\u2013509. https:\/\/doi.org\/10.1515\/hsz-2017-0260.","journal-title":"Biol Chem"},{"issue":"2","key":"566_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0167-4838(95)00202-2","volume":"1292","author":"J George","year":"1996","unstructured":"George J, Chandrakasan G. Molecular characteristics of dimethylnitrosamine induced fibrotic liver collagen. Biochim Biophys Acta. 1996;1292(2):215\u201322. https:\/\/doi.org\/10.1016\/0167-4838(95)00202-2.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"566_CR13","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/sj.gt.3302929","volume":"14","author":"J George","year":"2007","unstructured":"George J, Tsutsumi M. siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats. Gene Ther. 2007;14(10):790\u2013803. https:\/\/doi.org\/10.1038\/sj.gt.3302929.","journal-title":"Gene Ther"},{"issue":"2\u20133","key":"566_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/s0300-483x(00)00352-8","volume":"156","author":"J George","year":"2001","unstructured":"George J, Rao KR, Stern R, Chandrakasan G. Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagen. Toxicology. 2001;156(2\u20133):129\u201338. https:\/\/doi.org\/10.1016\/s0300-483x(00)00352-8.","journal-title":"Toxicology"},{"issue":"2","key":"566_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/s1357-2725(03)00253-x","volume":"36","author":"J George","year":"2004","unstructured":"George J, Tsutsumi M, Takase S. Expression of hyaluronic acid in N-nitrosodimethylamine induced hepatic fibrosis in rats. Int J Biochem Cell Biol. 2004;36(2):307\u201319. https:\/\/doi.org\/10.1016\/s1357-2725(03)00253-x.","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"566_CR16","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/bit.20939","volume":"95","author":"J George","year":"2006","unstructured":"George J, Kuboki Y, Miyata T. Differentiation of mesenchymal stem cells into osteoblasts on honeycomb collagen scaffolds. Biotechnol Bioeng. 2006;95(3):404\u201311. https:\/\/doi.org\/10.1002\/bit.20939.","journal-title":"Biotechnol Bioeng"},{"issue":"4","key":"566_CR17","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/jbm.a.32277","volume":"87","author":"J George","year":"2008","unstructured":"George J, Onodera J, Miyata T. Biodegradable honeycomb collagen scaffold for dermal tissue engineering. J Biomed Mater Res A. 2008;87(4):1103\u201311. https:\/\/doi.org\/10.1002\/jbm.a.32277.","journal-title":"J Biomed Mater Res A"},{"issue":"12","key":"566_CR18","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1111\/jcmm.13304","volume":"21","author":"J George","year":"2017","unstructured":"George J, Tsutsumi M, Tsuchishima M. MMP-13 deletion decreases profibrogenic molecules and attenuates N-nitrosodimethylamine-induced liver injury and fibrosis in mice. J Cell Mol Med. 2017;21(12):3821\u201335. https:\/\/doi.org\/10.1111\/jcmm.13304.","journal-title":"J Cell Mol Med"},{"issue":"7","key":"566_CR19","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41374-018-0053-4","volume":"98","author":"J George","year":"2018","unstructured":"George J, Yan IK, Patel T. Nanovesicle-mediated delivery of anticancer agents effectively induced cell death and regressed intrahepatic tumors in athymic mice. Lab Invest. 2018;98(7):895\u2013910. https:\/\/doi.org\/10.1038\/s41374-018-0053-4.","journal-title":"Lab Invest"},{"issue":"1","key":"566_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41419-018-1272-8","volume":"10","author":"J George","year":"2019","unstructured":"George J, Tsuchishima M, Tsutsumi M. Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis. Cell Death Dis. 2019a;10(1):18. https:\/\/doi.org\/10.1038\/s41419-018-1272-8.","journal-title":"Cell Death Dis"},{"key":"566_CR21","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41598-018-37516-4","volume":"9","author":"J George","year":"2019","unstructured":"George J, Tsutsumi M, Tsuchishima M. Alteration of trace elements during pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis. Sci Rep. 2019b;9:708. https:\/\/doi.org\/10.1038\/s41598-018-37516-4.","journal-title":"Sci Rep"},{"issue":"9","key":"566_CR22","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00109-020-01950-7","volume":"98","author":"J George","year":"2020","unstructured":"George J, Tsuchishima M, Tsutsumi M. Metabolism of N-nitrosodimethylamine, methylation of macromolecules, and development of hepatic fibrosis in rodent models. J Mol Med (berl). 2020;98(9):1203\u201313. https:\/\/doi.org\/10.1007\/s00109-020-01950-7.","journal-title":"J Mol Med (berl)"},{"key":"566_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113111","volume":"151","author":"J George","year":"2022","unstructured":"George J, Tsuchishima M, Tsutsumi M. Epigallocatechin-3-gallate inhibits osteopontin expression and prevents experimentally induced hepatic fibrosis. Biomed Pharmacother. 2022;151: 113111. https:\/\/doi.org\/10.1016\/j.biopha.2022.113111.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"566_CR24","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4252\/wjsc.v6.i5.526","volume":"6","author":"JD Glenn","year":"2014","unstructured":"Glenn JD, Whartenby KA. Mesenchymal stem cells: emerging mechanisms of immunomodulation and therapy. World J Stem Cells. 2014;6(5):526\u201339. https:\/\/doi.org\/10.4252\/wjsc.v6.i5.526.","journal-title":"World J Stem Cells"},{"issue":"3","key":"566_CR25","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1111\/jcmm.14115","volume":"23","author":"C Hu","year":"2019","unstructured":"Hu C, Zhao L, Duan J, Li L. Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis. J Cell Mol Med. 2019;23(3):1657\u201370. https:\/\/doi.org\/10.1111\/jcmm.14115.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"566_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1046\/j.1525-1594.2001.025003213.x","volume":"25","author":"H Itoh","year":"2001","unstructured":"Itoh H, Aso Y, Furuse M, Noishiki Y, Miyata T. A honeycomb collagen carrier for cell culture as a tissue engineering scaffold. Artif Organs. 2001;25(3):213\u20137. https:\/\/doi.org\/10.1046\/j.1525-1594.2001.025003213.x.","journal-title":"Artif Organs"},{"issue":"1","key":"566_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/jbm.a.31311","volume":"84","author":"N Kakudo","year":"2008","unstructured":"Kakudo N, Shimotsuma A, Miyake S, Kushida S, Kusumoto K. Bone tissue engineering using human adipose-derived stem cells and honeycomb collagen scaffold. J Biomed Mater Res A. 2008;84(1):191\u20137. https:\/\/doi.org\/10.1002\/jbm.a.31311.","journal-title":"J Biomed Mater Res A"},{"issue":"8","key":"566_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2014.49","volume":"46","author":"MD Kim","year":"2014","unstructured":"Kim MD, Kim SS, Cha HY, Jang SH, Chang DY, Kim W, Suh-Kim H, Lee JH. Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis. Exp Mol Med. 2014;46(8): e110. https:\/\/doi.org\/10.1038\/emm.2014.49.","journal-title":"Exp Mol Med"},{"issue":"1","key":"566_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41420-022-00846-4","volume":"8","author":"Q Liu","year":"2022","unstructured":"Liu Q, Lv C, Huang Q, Zhao L, Sun X, Ning D, Liu J, Jiang Y, Jin S. ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-\u03b2\/Smad signaling pathway. Cell Death Discov. 2022;8(1):51. https:\/\/doi.org\/10.1038\/s41420-022-00846-4.","journal-title":"Cell Death Discov"},{"issue":"3","key":"566_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118744","volume":"10","author":"Y Matsue","year":"2015","unstructured":"Matsue Y, Tsutsumi M, Hayashi N, Saito T, Tsuchishima M, Toshikuni N, Arisawa T, George J. Serum osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus infection. PLoS ONE. 2015;10(3): e0118744. https:\/\/doi.org\/10.1371\/journal.pone.0118744.","journal-title":"PLoS ONE"},{"issue":"6","key":"566_CR31","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2174\/1574888X11666160429122133","volume":"12","author":"A Mildmay-White","year":"2017","unstructured":"Mildmay-White A, Khan W. Cell surface markers on adipose-derived stem cells: a systematic review. Curr Stem Cell Res Ther. 2017;12(6):484\u201392. https:\/\/doi.org\/10.2174\/1574888X11666160429122133.","journal-title":"Curr Stem Cell Res Ther"},{"issue":"2","key":"566_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cps.2014.12.007","volume":"42","author":"DM Minteer","year":"2015","unstructured":"Minteer DM, Marra KG, Rubin JP. Adipose stem cells: biology, safety, regulation, and regenerative potential. Clin Plast Surg. 2015;42(2):169\u201379. https:\/\/doi.org\/10.1016\/j.cps.2014.12.007.","journal-title":"Clin Plast Surg"},{"issue":"18","key":"566_CR33","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.3748\/wjg.v20.i18.5442","volume":"20","author":"S Nusrat","year":"2014","unstructured":"Nusrat S, Khan MS, Fazili J, Madhoun MF. Cirrhosis and its complications: evidence based treatment. World J Gastroenterol. 2014;20(18):5442\u201360. https:\/\/doi.org\/10.3748\/wjg.v20.i18.5442.","journal-title":"World J Gastroenterol"},{"issue":"1\u20132","key":"566_CR34","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/pr.2017.249","volume":"83","author":"WS Park","year":"2018","unstructured":"Park WS, Ahn SY, Sung SI, Ahn JY, Chang YS. Strategies to enhance paracrine potency of transplanted mesenchymal stem cells in intractable neonatal disorders. Pediatr Res. 2018;83(1\u20132):214\u201322. https:\/\/doi.org\/10.1038\/pr.2017.249.","journal-title":"Pediatr Res"},{"key":"566_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.biocel.2015.09.003","volume":"68","author":"N Raafat","year":"2015","unstructured":"Raafat N, Abdel Aal SM, Abdo FK, El Ghonaimy NM. Mesenchymal stem cells: in vivo therapeutic application ameliorates carbon tetrachloride induced liver fibrosis in rats. Int J Biochem Cell Biol. 2015;68:109\u201318. https:\/\/doi.org\/10.1016\/j.biocel.2015.09.003.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"566_CR36","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/cells9040875","volume":"9","author":"N Roehlen","year":"2020","unstructured":"Roehlen N, Crouchet E, Baumert TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells. 2020;9(4):875. https:\/\/doi.org\/10.3390\/cells9040875.","journal-title":"Cells"},{"issue":"8","key":"566_CR37","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1002\/stem.459","volume":"28","author":"J Tolar","year":"2010","unstructured":"Tolar J, Le Blanc K, Keating A, Blazar BR. Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells. 2010;28(8):1446\u201355. https:\/\/doi.org\/10.1002\/stem.459.","journal-title":"Stem Cells"},{"issue":"7","key":"566_CR38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14(7):397\u2013411. https:\/\/doi.org\/10.1038\/nrgastro.2017.38.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"566_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3350\/cmh.2020.0194","volume":"27","author":"Y Watanabe","year":"2021","unstructured":"Watanabe Y, Tsuchiya A, Terai S. The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future. Clin Mol Hepatol. 2021;27(1):70\u201380. https:\/\/doi.org\/10.3350\/cmh.2020.0194.","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"566_CR40","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.yexcr.2014.04.017","volume":"326","author":"S Winkler","year":"2014","unstructured":"Winkler S, Borkham-Kamphorst E, Stock P, Br\u00fcckner S, Dollinger M, Weiskirchen R, Christ B. Human mesenchymal stem cells towards non-alcoholic steatohepatitis in an immunodeficient mouse model. Exp Cell Res. 2014;326(2):230\u20139. https:\/\/doi.org\/10.1016\/j.yexcr.2014.04.017.","journal-title":"Exp Cell Res"},{"issue":"3","key":"566_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1369\/0022155415627681","volume":"64","author":"F Xu","year":"2016","unstructured":"Xu F, Liu C, Zhou D, Zhang L. TGF-\u03b2\/SMAD pathway and its regulation in hepatic fibrosis. J Histochem Cytochem. 2016;64(3):157\u201367. https:\/\/doi.org\/10.1369\/0022155415627681.","journal-title":"J Histochem Cytochem"},{"key":"566_CR42","doi-asserted-by":"publisher","first-page":"1492694","DOI":"10.1155\/2016\/1492694","volume":"2016","author":"AT Yang","year":"2016","unstructured":"Yang AT, Hu DD, Wang P, Cong M, Liu TH, Zhang D, Sun YM, Zhao WS, Jia JD, You H. TGF-\u03b21 induces the dual regulation of hepatic progenitor cells with both anti- and proliver fibrosis. Stem Cells Int. 2016;2016:1492694. https:\/\/doi.org\/10.1155\/2016\/1492694.","journal-title":"Stem Cells Int"},{"key":"566_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.655268","volume":"8","author":"Y Yang","year":"2021","unstructured":"Yang Y, Zhao Y, Zhang L, Zhang F, Li L. The application of mesenchymal stem cells in the treatment of liver diseases: mechanism, efficacy, and safety issues. Front Med (lausanne). 2021;8: 655268. https:\/\/doi.org\/10.3389\/fmed.2021.655268.","journal-title":"Front Med (lausanne)"},{"issue":"1","key":"566_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010175","volume":"16","author":"N Yang","year":"2022","unstructured":"Yang N, Ma W, Ke Y, Liu H, Chu J, Sun L, L\u00fc G, Bi X, Lin R. Transplantation of adipose-derived stem cells ameliorates Echinococcus multilocularis-induced liver fibrosis in mice. PLoS Negl Trop Dis. 2022;16(1): e0010175. https:\/\/doi.org\/10.1371\/journal.pntd.0010175.","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"566_CR45","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/hepr.13635","volume":"51","author":"H Yatsuhashi","year":"2021","unstructured":"Yatsuhashi H, Sano H, Hirano T, Shibasaki Y. Real-world hospital mortality of liver cirrhosis inpatients in Japan: a large-scale cohort study using a medical claims database: prognosis of liver cirrhosis. Hepatol Res. 2021;51(6):682\u201393. https:\/\/doi.org\/10.1111\/hepr.13635.","journal-title":"Hepatol Res"},{"issue":"2","key":"566_CR46","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jfma.2012.12.002","volume":"114","author":"F Yu","year":"2015","unstructured":"Yu F, Ji S, Su L, Wan L, Zhang S, Dai C, Wang Y, Fu J, Zhang Q. Adipose-derived mesenchymal stem cells inhibit activation of hepatic stellate cells in vitro and ameliorate rat liver fibrosis in vivo. J Formos Med Assoc. 2015;114(2):130\u20138. https:\/\/doi.org\/10.1016\/j.jfma.2012.12.002.","journal-title":"J Formos Med Assoc"},{"issue":"6","key":"566_CR47","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1136\/gutjnl-2011-300908","volume":"61","author":"DS Zagoura","year":"2012","unstructured":"Zagoura DS, Roubelakis MG, Bitsika V, Trohatou O, Pappa KI, Kapelouzou A, Antsaklis A, Anagnou NP. Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure. Gut. 2012;61(6):894\u2013906. https:\/\/doi.org\/10.1136\/gutjnl-2011-300908.","journal-title":"Gut"},{"key":"566_CR48","doi-asserted-by":"publisher","first-page":"6546780","DOI":"10.1155\/2021\/6546780","volume":"2021","author":"M Zhu","year":"2021","unstructured":"Zhu M, Hua T, Ouyang T, Qian H, Yu B. Applications of mesenchymal stem cells in liver fibrosis: novel strategies, mechanisms, and clinical practice. Stem Cells Int. 2021;2021:6546780. https:\/\/doi.org\/10.1155\/2021\/6546780.","journal-title":"Stem Cells Int"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-022-00566-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-022-00566-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-022-00566-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T12:13:36Z","timestamp":1669724016000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-022-00566-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["566"],"URL":"https:\/\/doi.org\/10.1186\/s10020-022-00566-6","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,29]]},"assertion":[{"value":"26 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the Ethics and Clinical Investigation Committee of Kanazawa Medical University, Ishikawa, Japan (#G129) and has been conducted according to the principles outlined in the Declaration of Helsinki (revised 2013).The animal experiments protocol (#2017-89) was approved by the Animal Care and Use Committee of Kanazawa Medical University on the Ethics in the care and use of experimental animals. (#2017-89).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors do not have any conflicts of interest to declare in connection with this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}